Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Senthil K. Muthuswamy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6564-9634; OpenAlex author ID A5024732613. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
45
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 10

  1. A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial. Co-author DOI 10.1158/1078-0432.ccr-23-4026↗
  2. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. Last author DOI 10.7554/elife.87369↗
  3. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer Last author DOI 10.7554/elife.87369.3↗
  4. Personalized tumor vaccine for pancreatic cancer. Co-author DOI 10.1007/s00262-022-03237-x↗
  5. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-4116↗
  6. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Co-author DOI 10.1016/j.cell.2021.07.020↗
  7. Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer. Co-author DOI 10.1038/s41598-021-84852-z↗
  8. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells. Co-author DOI 10.1158/1535-7163.mct-19-1166↗
  9. Personalized RNA Medicine for Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-2733↗
  10. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Last author DOI 10.1038/nm.3973↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Manuel M. Hidalgo · 7 shared papers, 2018–2025 · strength 0.81
  2. Ling Huang · 7 shared papers, 2015–2024 · strength 0.80
  3. Bruno Bockorny · 5 shared papers, 2020–2025 · strength 0.73
  4. Andrea J. Bullock · 3 shared papers, 2022–2024 · strength 0.45
  5. Joseph Elan Grossman · 3 shared papers, 2022–2024 · strength 0.45
  6. Leo L. Tsai · 3 shared papers, 2022–2024 · strength 0.45
  7. Mandeep Sawhney · 3 shared papers, 2022–2024 · strength 0.45
  8. Steven D. Freedman · 2 shared papers, 2024 · strength 0.33
  9. Rocio García‐Carbonero · 1 shared paper, 2025 · strength 0.19
  10. Francesca Sarno · 1 shared paper, 2025 · strength 0.19
  11. Roberto Pazo-Cid · 1 shared paper, 2025 · strength 0.19
  12. Carmen E. Guerra · 1 shared paper, 2025 · strength 0.19
  13. Carmen Guillén‐Ponce · 1 shared paper, 2025 · strength 0.19
  14. Jaime Feliú · 1 shared paper, 2025 · strength 0.19
  15. Shira Orr · 1 shared paper, 2023 · strength 0.15
  16. David Avigan · 1 shared paper, 2023 · strength 0.15
  17. Donald W. Kufe · 1 shared paper, 2023 · strength 0.15
  18. Mary Linton B. Peters · 1 shared paper, 2022 · strength 0.11
  19. Mark P. Callery · 1 shared paper, 2022 · strength 0.11
  20. Raul S. González · 1 shared paper, 2022 · strength 0.11
  21. Tara Sotsky Kent · 1 shared paper, 2022 · strength 0.11
  22. Douglas K. Pleskow · 1 shared paper, 2022 · strength 0.11
  23. Spas Dimitrov Markov · 1 shared paper, 2020 · strength 0.09
  24. Tulin Dadali · 1 shared paper, 2021 · strength 0.09
  25. Shin Kibe · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.